CIBR vs XBI
First Trust NASDAQ Cybersecurity ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.58% for CIBR.
- • CIBR pays a higher dividend yield (0.44%).
Side-by-side metrics
| Metric | CIBR | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.58% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.44% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $13.84B | $10.73B |
YTD return | 28.62% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 1.10 |
P/E ratio | 31.93 | — |
Last price | $94.26 | $164.28 |
Inception | — | — |
Issuer | First Trust | State Street |
CIBR top holdings
| PANW | Palo Alto Networks Inc | 9.61% |
| FTNT | Fortinet Inc | 8.84% |
| CRWD | CrowdStrike Holdings Inc Class A | 8.29% |
| CSCO | Cisco Systems Inc | 7.75% |
| AVGO | Broadcom Inc | 6.72% |
| NET | Cloudflare Inc | 4.03% |
| OKTA | Okta Inc Class A | 3.52% |
| FFIV | F5 Inc | 3.41% |
| ZS | Zscaler Inc | 3.04% |
| AKAM | Akamai Technologies Inc | 2.84% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About CIBR
CIBR (First Trust NASDAQ Cybersecurity ETF) is Cybersecurity companies providing network security. Managed by First Trust, the fund carries $13.8B in assets under management, an expense ratio of 0.58%, a dividend yield of 0.44%. Its largest holding is Palo Alto Networks Inc (PANW), which represents 9.6% of the portfolio. Technology is the fund's largest sector exposure at 94.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.